
Denali Therapeutics
Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
About
Denali Therapeutics is a biopharmaceutical company focused on discovering, developing, and delivering medicines for people living with serious diseases, particularly neurodegenerative conditions. Their core strategy involves creating therapies that can effectively cross the blood-brain barrier using their proprietary Transport Vehicle (TV) technology. The company aims to address debilitating conditions such as Alzheimer's, Parkinson's, and ALS.
Show 6 more similar companies
Similar companies
Developing novel therapeutics for neurodegenerative diseases using advanced biological insights.
Shares Biotech, HealthTech
Developing novel therapies for neurological disorders.
Shares Biotech, HealthTech
Restores glutamate homeostasis by targeting astrocyte biology, breaking the cycle of excitotoxicity across CNS diseases.
Shares Biotech, HealthTech
Biopharmaceutical company targeting neurodegeneration and aging by modulating the immune system.
Shares Biopharmaceutical, Biotech
Prophet Bio is a biotech startup focused on developing novel therapeutics for neurodegenerative diseases.
Shares Biotech, Drug Discovery
A biotechnology company developing genetic therapies for rare disorders.
Shares Drug Discovery
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Denali Therapeutics?
People comparing tools land here. Get listed beside these.
Copy Denali Therapeutics's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- denalitherapeutics.com
- Headquarters
- South San Francisco, United States
- Founded
- 2015
- Founders
- Alexander Schuth, Marc Tessier-Lavigne, Ryan Watts
- Total funding
- $1.0B (Royalty Funding)
- Business model
- B2B
Funding rounds
- $200M27 Mar 2026
- $500M27 Feb 2024Post IPOLargest round
- $130M25 Aug 2016
- $217M14 May 2015
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 27 Mar 2026 | Royalty Funding | $200M | |
| 27 Feb 2024 | Post IPO | $500M | |
| 25 Aug 2016 | Series B | $130M | |
| 14 May 2015 | Series A | $217M |
Tech stack
Detected on denalitherapeutics.com, last scanned 13 Nov 2026. Run your own scan
- Compliance
- GDPR, CCPA
- Frontend
- Tailwind CSS
- Analytics
- Segment
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Accessibility
- UserWay
Benchmarking
See how your site ranks against 16,849 startups
Denali Therapeutics sits in the 65th percentile for Domain Rating. Check where yours lands, free.
Denali Therapeutics has a Domain Rating of 56, the 65th percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Above median
Check yoursAgent Readiness
Below median
Scan yoursSite Speed
Above median
PageSpeedData Trust
Top 25%
Security
Click to scan
Agent Readiness
Can AI agents use your site?
Denali Therapeutics scores 39. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Denali Therapeutics changes
Used Denali Therapeutics? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
How people find Denali Therapeutics on Google
Searches that showed this page, last 28 days
- startuphub$$$29 seen#1
- denali therapeutics$$$2 seen#42
- denali biotech$$$2 seen#40
$$$ high buyer intent (pricing, reviews, alternatives), $$ brand searches, $ research. Read from the wording, not ad prices.
Frequently asked
Is Denali Therapeutics growing?
Yes, fast. Our data shows it raised $200M in a Royalty Funding in March 2026.
Who owns Denali Therapeutics?
Denali Therapeutics is privately held, owned by its founders and investors. Arch Venture Partners has backed 2 of the 4 rounds on record since May 2015, ahead of F-Prime Capital (2), so it is likely among the largest outside shareholders. Exact stakes are not public.
Are there companies like Denali Therapeutics?
Yes. We list 6 companies like Denali Therapeutics, including Anamnesis Bio, Tahoe Therapeutics and iQure Pharma .. Denali Therapeutics stands out on funding: its $1B is more than any of them has raised, the nearest being Rocket Pharmaceuticals at $533M.
Is Denali Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Denali Therapeutics is 90 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Denali Therapeutics raised?
Denali Therapeutics has raised a total of $1.0B in funding. The most recent round on record is Royalty Funding.
SEC filings, insider activity, nonprofit links and pay benchmarks for Denali Therapeutics:
Company details: from public sources. Funding: 4 rounds on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Denali Therapeutics and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini


